To verify whether TPL2 is functionally associated with ADI prostate cancer cell growth, we investigated the functional consequences of the overexpression or suppression of TPL2 in AD or ADI prostate cancer cells, respectively. This evidence concerns the gene MAP3K8 and prostate carcinoma.